Rationale and design of a multicentre, randomized, placebo-controlled trial of mirabegron, a Beta3-adrenergic receptor agonist on left ventricular mass and diastolic function in patients with structural heart disease Beta3-left ventricular hypertroph

Rationale and design of a multicentre, randomized, placebo-controlled trial of mirabegron, a Beta3-adrenergic receptor agonist on left ventricular mass and diastolic function in patients with structural heart disease Beta3-left ventricular hypertroph

Item

http://www.wikidata.org/entity/Q56968615

Q56968615

about

Rationale and design of a multicentre, randomized, placebo-controlled trial of mirabegron, a Beta3-adrenergic receptor agonist on left ventricular mass and diastolic function in patients with structural heart disease Beta3-left ventricular hypertroph

Item

http://www.wikidata.org/entity/Q56968615

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована в жовтні 2018

@uk

name

Rationale and design of a mult ...... a3-left ventricular hypertroph

@en

Rationale and design of a mult ...... a3-left ventricular hypertroph

@nl

type

Item

label

Rationale and design of a mult ...... a3-left ventricular hypertroph

@en

Rationale and design of a mult ...... a3-left ventricular hypertroph

@nl

prefLabel

Rationale and design of a mult ...... a3-left ventricular hypertroph

@en

Rationale and design of a mult ...... a3-left ventricular hypertroph

@nl

P1476

Rationale and design of a mult ...... a3-left ventricular hypertroph

@en

P2093

Alexandre Persu

http://www.w3.org/2001/XMLSchema#string

Anne-Catherine Pouleur

http://www.w3.org/2001/XMLSchema#string

Barbara Casadei

http://www.w3.org/2001/XMLSchema#string

Bernhard L Gerber

http://www.w3.org/2001/XMLSchema#string

Damien Gruson

http://www.w3.org/2001/XMLSchema#string

Dirk Hasenclever

http://www.w3.org/2001/XMLSchema#string

Dulce Brito

http://www.w3.org/2001/XMLSchema#string

Elisabeth Pieske-Kraigher

http://www.w3.org/2001/XMLSchema#string

Frank Edelmann

http://www.w3.org/2001/XMLSchema#string

Ignatios Ikonomidis

http://www.w3.org/2001/XMLSchema#string

P2860

2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration

Sequential Treatment Assignment with Balancing for Prognostic Factors in the Controlled Clinical Trial

Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association

Rate control efficacy in permanent atrial fibrillation: successful and failed strict rate control against a background of lenient rate control: data from RACE II (Rate Control Efficacy in Permanent Atrial Fibrillation).

Vericiguat in patients with worsening chronic heart failure and preserved ejection fraction: results of the SOluble guanylate Cyclase stimulatoR in heArT failurE patientS with PRESERVED EF (SOCRATES-PRESERVED) study

Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures: A comparative simultaneous Doppler-catheterization study.

Non-contrast T1-mapping detects acute myocardial edema with high diagnostic accuracy: a comparison to T2-weighted cardiovascular magnetic resonance.

2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

Spironolactone for heart failure with preserved ejection fraction.

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contrib

P304

830-841

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/EHF2.12306

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2018-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29932311

http://www.w3.org/2001/XMLSchema#string

P921

placebo

diastole

P932

6165933

http://www.w3.org/2001/XMLSchema#string

Rationale and design of a multicentre, randomized, placebo-controlled trial of mirabegron, a Beta3-adrenergic receptor agonist on left ventricular mass and diastolic function in patients with structural heart disease Beta3-left ventricular hypertroph

about

Rationale and design of a multicentre, randomized, placebo-controlled trial of mirabegron, a Beta3-adrenergic receptor agonist on left ventricular mass and diastolic function in patients with structural heart disease Beta3-left ventricular hypertroph

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932